TY - JOUR
T1 - Clinical Consequences of Metabolic Acidosis—Muscle
AU - Ho, Jim Q.
AU - Abramowitz, Matthew K.
N1 - Funding Information:
Financial Disclosure: M.K.A. has received consulting fees from Tricida, Inc. J.Q.H. declares no relevant financial interests.
Publisher Copyright:
© 2022 National Kidney Foundation, Inc.
PY - 2022/7
Y1 - 2022/7
N2 - Metabolic acidosis is common in people with chronic kidney disease and can contribute to functional decline, morbidity, and mortality. One avenue through which metabolic acidosis can result in these adverse clinical outcomes is by negatively impacting skeletal muscle; this can occur through several pathways. First, metabolic acidosis promotes protein degradation and impairs protein synthesis, which lead to muscle breakdown. Second, metabolic acidosis hinders mitochondrial function, which decreases oxidative phosphorylation and reduces energy production. Third, metabolic acidosis directly limits muscle contraction. The purpose of this review is to examine the specific mechanisms of each pathway through which metabolic acidosis affects muscle, the impact of metabolic acidosis on physical function, and the effect of treating metabolic acidosis on functional outcomes.
AB - Metabolic acidosis is common in people with chronic kidney disease and can contribute to functional decline, morbidity, and mortality. One avenue through which metabolic acidosis can result in these adverse clinical outcomes is by negatively impacting skeletal muscle; this can occur through several pathways. First, metabolic acidosis promotes protein degradation and impairs protein synthesis, which lead to muscle breakdown. Second, metabolic acidosis hinders mitochondrial function, which decreases oxidative phosphorylation and reduces energy production. Third, metabolic acidosis directly limits muscle contraction. The purpose of this review is to examine the specific mechanisms of each pathway through which metabolic acidosis affects muscle, the impact of metabolic acidosis on physical function, and the effect of treating metabolic acidosis on functional outcomes.
KW - Acidosis
KW - Bicarbonate
KW - Chronic kidney disease
KW - Muscle
KW - Physical function
UR - http://www.scopus.com/inward/record.url?scp=85138824503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138824503&partnerID=8YFLogxK
U2 - 10.1053/j.ackd.2022.04.010
DO - 10.1053/j.ackd.2022.04.010
M3 - Review article
C2 - 36175077
AN - SCOPUS:85138824503
SN - 1548-5595
VL - 29
SP - 395
EP - 405
JO - Advances in Chronic Kidney Disease
JF - Advances in Chronic Kidney Disease
IS - 4
ER -